Table 1.
Characteristics | No.of patients |
miR-365a-3p | p value | |
---|---|---|---|---|
low(N=67) | High (N=67) | |||
Gender | 0.862 | |||
Female | 59 | 29 | 30 | |
Male | 75 | 38 | 37 | |
Age(years) | 0.849 | |||
<60 | 39 | 19 | 20 | |
≥60 | 95 | 48 | 47 | |
Tumor location | 0.073 | |||
Recturn | 60 | 29 | 31 | |
Colon | 74 | 38 | 36 | |
Differentiation grade | 0.685 | |||
Well+Moderate | 102 | 50 | 52 | |
Poor | 32 | 17 | 15 | |
Tumer size (cm) | 0.022 | |||
<5 | 53 | 20 | 33 | |
≥5 | 81 | 47 | 34 | |
Local invasion | 0.043 | |||
pT1-T2 | 102 | 46 | 56 | |
pT3-T4 | 32 | 21 | 11 | |
Lymph node metastasis | 0.021 | |||
N0+N1 | 83 | 35 | 48 | |
N2 | 51 | 32 | 19 | |
TNM stage | 0.291 | |||
Ⅰ+Ⅱ | 80 | 37 | 43 | |
Ⅲ | 54 | 30 | 24 | |
CA19-9(kU/L) | 0.604 | |||
<37 | 63 | 30 | 33 | |
≥37 | 71 | 37 | 34 | |
Serum CEA level (ng/mL) | 0.166 | |||
<5 | 59 | 31 | 28 | |
≥5 | 75 | 36 | 39 |
Carbohydrate Antigen 19-9, CA19-9; Carcinoembryonic Antigen,CEA